Immunomodulation: checkpoint blockade etc.

被引:28
作者
Curry, William T. [1 ,2 ]
Lim, Michael [3 ]
机构
[1] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21287 USA
关键词
biomarker; checkpoint blockade; clinical trial; glioblastoma; immunotherapy; MONOCLONAL-ANTIBODIES; CTLA-4; IPILIMUMAB; MELANOMA; RADIATION; CELLS; PD-1; PEMBROLIZUMAB; COMBINATION; BIOMARKERS;
D O I
10.1093/neuonc/nov174
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The immune microenvironment is considered a major obstacle to generating an effective antitumor immune response. Checkpoint inhibitors manipulate the co-stimulatory response between antigen-presenting cells and immune cells-or between the tumor and immune cells-to elicit an antitumor immune response that would have otherwise been suppressed. Checkpoint inhibitors have shown great promise in the clinics, and some inhibitors such as anti-CTLA-4 antibodies and anti-PD-1 antibodies have gained FDA approval for certain tumors. Here we will discuss the current state of checkpoint inhibitors, biomarker strategies, and management of associated toxicities in glioblastoma.
引用
收藏
页码:26 / 31
页数:6
相关论文
共 34 条
[1]   Sequential Immunotherapy by Vaccination With GM-CSF-expressing Glioma Cells and CTLA-4 Blockade Effectively Treats Established Murine Intracranial Tumors [J].
Agarwalla, Pankaj ;
Barnard, Zachary ;
Fecci, Peter ;
Dranoff, Glenn ;
Curry, William T., Jr. .
JOURNAL OF IMMUNOTHERAPY, 2012, 35 (05) :385-389
[2]  
[Anonymous], J CLIN ONCOL S
[3]   Biomarkers for Immunostimulatory Monoclonal Antibodies in Combination Strategies for Melanoma and Other Tumor Types [J].
Ascierto, Paolo A. ;
Kalos, Michael ;
Schaer, David A. ;
Callahan, Margaret K. ;
Wolchok, Jedd D. .
CLINICAL CANCER RESEARCH, 2013, 19 (05) :1009-1020
[4]   Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].
Brahmer, Julie ;
Reckamp, Karen L. ;
Baas, Paul ;
Crino, Lucio ;
Eberhardt, Wilfried E. E. ;
Poddubskaya, Elena ;
Antonia, Scott ;
Pluzanski, Adam ;
Vokes, Everett E. ;
Holgado, Esther ;
Waterhouse, David ;
Ready, Neal ;
Gainor, Justin ;
Aren Frontera, Osvaldo ;
Havel, Libor ;
Steins, Martin ;
Garassino, Marina C. ;
Aerts, Joachim G. ;
Domine, Manuel ;
Paz-Ares, Luis ;
Reck, Martin ;
Baudelet, Christine ;
Harbison, Christopher T. ;
Lestini, Brian ;
Spigel, David R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135
[5]   Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function [J].
Fecci, Peter E. ;
Ochiai, Hidenobu ;
Mitchell, Duane A. ;
Grossi, Peter M. ;
Sweeney, Alison E. ;
Archer, Gary E. ;
Cummings, Thomas ;
Allison, James P. ;
Bigner, Darell D. ;
Sampson, John H. .
CLINICAL CANCER RESEARCH, 2007, 13 (07) :2158-2167
[6]   Too Much of a Good Thing? Tim-3 and TCR Signaling in T Cell Exhaustion [J].
Ferris, Robert L. ;
Lu, Binfeng ;
Kane, Lawrence P. .
JOURNAL OF IMMUNOLOGY, 2014, 193 (04) :1525-1530
[7]   Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation [J].
Freeman, GJ ;
Long, AJ ;
Iwai, Y ;
Bourque, K ;
Chernova, T ;
Nishimura, H ;
Fitz, LJ ;
Malenkovich, N ;
Okazaki, T ;
Byrne, MC ;
Horton, HF ;
Fouser, L ;
Carter, L ;
Ling, V ;
Bowman, MR ;
Carreno, BM ;
Collins, M ;
Wood, CR ;
Honjo, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1027-1034
[8]   Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer [J].
Garon, Edward B. ;
Rizvi, Naiyer A. ;
Hui, Rina ;
Leighl, Natasha ;
Balmanoukian, Ani S. ;
Eder, Joseph Paul ;
Patnaik, Amita ;
Aggarwal, Charu ;
Gubens, Matthew ;
Horn, Leora ;
Carcereny, Enric ;
Ahn, Myung-Ju ;
Felip, Enriqueta ;
Lee, Jong-Seok ;
Hellmann, Matthew D. ;
Hamid, Omid ;
Goldman, Jonathan W. ;
Soria, Jean-Charles ;
Dolled-Filhart, Marisa ;
Rutledge, Ruth Z. ;
Zhang, Jin ;
Lunceford, Jared K. ;
Rangwala, Reshma ;
Lubiniecki, Gregory M. ;
Roach, Charlotte ;
Emancipator, Kenneth ;
Gandhi, Leena .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) :2018-2028
[9]   Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide [J].
Grossman, Stuart A. ;
Ye, Xiaobu ;
Lesser, Glenn ;
Sloan, Andrew ;
Carraway, Hetty ;
Desideri, Serena ;
Piantadosi, Steven .
CLINICAL CANCER RESEARCH, 2011, 17 (16) :5473-5480
[10]  
Grosso J, 2013, J CLIN ONCOL, V31